Board of Directors
The Institute’s Board of Directors is responsible for strategic planning, oversight, and executive management.
Board of Directors
Geoffrey A. Simon (Board Chair)
-Managing Director and Senior Vice President, Investments, Simon & Associates Wealth Management
Dan Browne
– President and CEO, Tasman Therapeutics
Landon S. King, M.D.
– The Johns Hopkins University School of Medicine
Milton Maltz
-Founder
Tamar Maltz
-Founder
Robert F. Muse, Esq.
-Partner, Cunningham Levy Muse LLP
Mary Rubin
-Founder
Ken Sonnenfeld, Ph.D., J.D.
-Intellectual Property Partner, Ballard Spahr
Steven S. Sharfstein, M.D.
– Former President and CEO of Sheppard Pratt Health System
Heidi Wagner, J.D.
-Senior Vice President and Global Head of Government Affairs, ElevateBio
Katrine Thor Andersen, MBA, MSc
-Principal, Strategic Business Development Consulting, Bering Impact LLC
Daniel R. Weinberger, M.D.
– Director and Chief Executive Officer of the Lieber Institute for Brain Development